A new vaccine called Provenge has just been accepted by the FDA, making it the first to be approved by the agency for men fighting advanced prostate cancer. While Provenge is not a cure, it has shown promise in extending the lives of patients.

The treatment won’t come cheap, however, at $93,000 per patient. –JCL

The BBC:

A “vaccine” which harnesses the body’s own immune system to fight prostate cancer has been approved for use by US drug regulators.

Provenge — which is designed to be used in men with advanced disease — is the first of its kind to be accepted by the Food and Drug Administration.

Each dose has to be individually tailored and it is an expensive treatment at $93,000 per patient.

It will add to, rather than replace, existing treatments, said experts.

Read more

Your support is crucial...

As we navigate an uncertain 2025, with a new administration questioning press freedoms, the risks are clear: our ability to report freely is under threat.

Your tax-deductible donation enables us to dig deeper, delivering fearless investigative reporting and analysis that exposes the reality beneath the headlines — without compromise.

Now is the time to take action. Stand with our courageous journalists. Donate today to protect a free press, uphold democracy and uncover the stories that need to be told.

SUPPORT TRUTHDIG